| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817304 | Clinica Chimica Acta | 2005 | 7 Pages |
Abstract
The diagnostic and prognostic potential of anti-CCP antibodies and the availability of a fully automated assay method lead us to conclude that the test is satisfactory for routine use as a serological marker of RA. In addition, we consider the potential of multiplex autoantibody assays, including miniaturized, high-throughput microarray technology, to improve diagnosis and prognostication in early onset arthritis patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
M. Tampoia, V. Brescia, A. Fontana, P. Maggiolini, A. Zucano, N. Pansini,